Gemin X Pharmaceuticals Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$225M
Gemin X Pharmaceuticals General Information
Description
Manufacturer of cancer therapeutics and drugs in the United States. The company provides GX15-070, a small molecule that reinitiates programmed cell death and apoptosis; GMX1777, which is a small molecule and inhibitor of NAD+ synthesis; and other oncology products, providing patients with cures and relief to various cancer inflections.
Contact Information
Website
www.geminx.comCorporate Office
- 3575 Avenue du Parc
- Suite 4310
- Montreal, Quebec
- Canada
Corporate Office
- 3575 Avenue du Parc
- Suite 4310
- Montreal, Quebec
- Canada
Gemin X Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 01-Apr-2011 | $225M | Completed | Clinical Trials - Phase 2 | ||
| 8. Later Stage VC (Series E) | 04-Aug-2010 | Completed | Product Development | |||
| 7. Later Stage VC (Series D) | 20-Apr-2010 | Completed | Product Development | |||
| 6. Later Stage VC (Series C) | 01-Jul-2008 | Completed | Product Development | |||
| 5. Later Stage VC | 19-May-2005 | Completed | Product Development | |||
| 4. Early Stage VC | 01-Jan-2002 | Completed | Product Development | |||
| 3. Early Stage VC | 24-Aug-2001 | Completed | Product Development | |||
| 2. Early Stage VC (Series B) | 03-May-2001 | $12.6M | $15.6M | Completed | Product Development | |
| 1. Early Stage VC (Series A) | 01-Jan-1998 | $3M | $3M | Completed | Product Development |
Gemin X Pharmaceuticals Comparisons
Industry
Financing
Details
Gemin X Pharmaceuticals Competitors (24)
One of Gemin X Pharmaceuticals’s 24 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Ayala Pharmaceuticals | Corporation | Wilmington, DE | ||||
| Altimmune | Formerly VC-backed | Gaithersburg, MD | ||||
| BioNTech | Formerly VC-backed | Mainz, Germany | ||||
| Centrose | Venture Capital-Backed | Madison, WI |
Gemin X Pharmaceuticals Former Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BDC Capital | Growth/Expansion | Minority | ||
| CDP Innovation-Sofinov | Venture Capital | Minority | ||
| Fonds de solidarite FTQ | PE/Buyout | Minority | ||
| GrowthWorks | Venture Capital | Minority | ||
| H.I.G. HealthBridge Partners | Growth/Expansion | Minority |
Gemin X Pharmaceuticals FAQs
-
When was Gemin X Pharmaceuticals founded?
Gemin X Pharmaceuticals was founded in 1998.
-
Where is Gemin X Pharmaceuticals headquartered?
Gemin X Pharmaceuticals is headquartered in Montreal, Canada.
-
What industry is Gemin X Pharmaceuticals in?
Gemin X Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Gemin X Pharmaceuticals a private or public company?
Gemin X Pharmaceuticals is a Private company.
-
What is the current valuation of Gemin X Pharmaceuticals?
The current valuation of Gemin X Pharmaceuticals is .
-
What is Gemin X Pharmaceuticals’s current revenue?
The current revenue for Gemin X Pharmaceuticals is .
-
How much funding has Gemin X Pharmaceuticals raised over time?
Gemin X Pharmaceuticals has raised $158M.
-
Who are Gemin X Pharmaceuticals’s investors?
BDC Capital, CDP Innovation-Sofinov, Fonds de solidarite FTQ, GrowthWorks, and H.I.G. HealthBridge Partners are 5 of 19 investors who have invested in Gemin X Pharmaceuticals.
-
Who are Gemin X Pharmaceuticals’s competitors?
Kite Pharma, Ayala Pharmaceuticals, Altimmune, BioNTech, and Centrose are some of the 24 competitors of Gemin X Pharmaceuticals.
-
When was Gemin X Pharmaceuticals acquired?
Gemin X Pharmaceuticals was acquired on 01-Apr-2011.
-
Who acquired Gemin X Pharmaceuticals?
Gemin X Pharmaceuticals was acquired by Cephalon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process